Nuveen Multistate Trust II has released its latest NPORT-P report, detailing its financial standing as of August 31, 2026. The filing, submitted on October 29, 2026, shows that the trust holds total assets exceeding $1.17 billion, with net assets reported at approximately $920 million. This information is significant for investors and stakeholders as it reflects the trust's performance in the competitive investment landscape.
Nuveen Multistate Trust II, incorporated in Massachusetts, operates as an investment entity. The trust focuses on municipal bonds, particularly those associated with California. Its recent filings include multiple NPORT-P submissions, with the latest being part of a series of reports filed on the same day, indicating a proactive approach to transparency.
The NPORT-P filing indicates that the trust's total liabilities stand at about $253 million. This positions the trust favorably, as its net assets suggest a solid financial footing. The report also highlights the trust's investment in various municipal bonds, which are crucial for funding public projects and infrastructure.
The filing states, "Total assets: $1,173,293,683; Total liabilities: $253,178,445; Net assets: $920,115,238."
This update is particularly relevant for investors in the municipal bond market, as it provides insights into the trust's investment strategy and financial health. Competitors in the investment sector will also be watching closely, as such disclosures can influence market dynamics and investor confidence.
Looking ahead, the trust is expected to continue its reporting practices, maintaining transparency with stakeholders. The filing does not specify what happens next, but further updates are anticipated as the trust navigates the evolving market landscape.
Read Next
Kinney Virginia reports stock transaction in NRG Energy
Fitzgerald Scott Michael reports share transaction at StubHub
Baker Eric Howard Acquires 18,130 Shares of StubHub Holdings
Hart Scott Barton Acquires Shares in NRG Energy, Inc.
Arcutis Biotherapeutics reports stock ownership update
Jazz Pharmaceuticals Director Sells 6,000 Shares in Transaction





